Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjogren's syndrome.

, , , , , , , , , (+5 more)

Annals of the rheumatic diseases Vol. 77 (12) : 1838-1840 • Dec 2018

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 29936436

DOI: 10.1136/annrheumdis-2018-213036 [doi]

Publication Year: 2018

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.